Quick Answer
BioScience Health Innovations, Inc. reported Diluted EPS of $0.06 per share for fiscal year 2025.
BioScience Health Innovations, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.06 | +500.0% |
| 2024 | $0.01 | +200.0% |
| 2023 | -$0.01 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.00 | -100.0% | -100.0% |
| June 30, 2025 | $0.01 | — | +0.0% |
| March 31, 2025 | $0.01 | — | +0.0% |
| September 30, 2024 | $0.01 | — | — |
| June 30, 2024 | $0.00 | — | — |
| March 31, 2024 | $0.00 | — | — |
| September 30, 2023 | $0.00 | — | — |
- BioScience Health Innovations, Inc. showed an increase of +500.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2023–2025 period, BioScience Health Innovations, Inc.’s diluted eps has grown by 700.0% (from $0.01 per share (loss) to $0.06 per share).
- The most recent figure is from BioScience Health Innovations, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: